Introduction
Retinal artery occlusion is a rare, yet potentially devastating complication of phacoemulsification cataract surgery. 1 We describe three patients presenting with acute post-operative visual loss following microincision phacoemulsification cataract surgery under sub-Tenon's anaesthesia (3 ml of 2% lignocaine and 500 units of hyaluronate without adrenaline), each diagnosed with transient retinal artery occlusion (TRAO). All procedures were uncomplicated with a surgical duration of o20 min with standard infusion pressures. We describe the variable nature of clinical presentation and imaging studies in each case.
Case series

Case 1
A 74-year-old male presented on post-operative day 1 with visual acuity of counting fingers, improving to 6/18 with a pinhole in the left eye. Fundal appearance was symmetrical and unremarkable, demonstrating mild age-related maculopathy with fine retinal epithelial pigmentary changes (Figures 1a and b) . Ten days later, vision improved to 6/18 (6/9 with a pinhole). There was no relative afferent pupillary defect. Paired OCT images 16 days post-operatively revealed subtle loss of laminar definition OS, noted only in retrospect, but retinal thickening was not present (Figures 1a  and b lens was undertaken and photorefractive keratectomy thereafter to eliminate remaining cylindrical error. However, visual acuity remained at 6/18 OS (6/9 with a pinhole). Farnsworth-Munsell 100 hue revealed poor colour discrimination OS. Nine months later, left inner retinal atrophy was evident confirming the diagnosis of TRAO (Figures 1d and e) . A carotid ultrasonography and cardiac investigations did not reveal any abnormalities.
Case 2
A 46-year-old male presented on post-operative day 1 with a right superior scotoma and visual acuity of 6/9 OD. There was no cardiovascular history of note at presentation. Dilated fundus examination revealed inferior macular opacification but no embolus (Figure 2a) . FFA revealed normal retinal arterial and retinal capillary perfusion (Figure 2b ). Visual field assessment revealed a dense superior scotoma, extending inferotemporally (Figure 2c ). OCT demonstrated asymmetric right inferior inner retinal thickening, not present superiorly (Figures 2d and e) . One month later, visual acuity was 6/5 OD with persistent visual field defect, although retinal appearance had normalised. Echocardiography revealed a patent foramen ovale, which was closed on cardiac catheterisation. Two years later, vision remained at 6/5, although OCT revealed right inferior inner retinal atrophy ( Figure 2f ).
Case 3
A 52-year-old male presented on post-operative day 4 with a left-sided central, circular scotoma noted in the immediate post-operative period. He had known atrial fibrillation for which he took sotalol and warfarin daily (international normalised ratio was 2.7 at the time of surgery). Fundal examination revealed a cherry-red spot at the fovea. FFA demonstrated perifoveal hypoperfusion, although no discrete arterial occlusion was seen (Figure 3a ). Seven sessions of hyperbaric oxygen therapy were undertaken in the first postoperative month, starting on post-operative day 7. OCT revealed diffuse inner retinal thickening (Figure 3b ), followed by inner retinal atrophy 1 year later (Figure 3c) . Vision improved over a 2-year period to 6/6 with reduced red saturations.
Discussion
TRAO is a potentially underdiagnosed cause of acute post-operative visual loss in patients undergoing nontopical phacoemulsification cataract surgery under local anaesthesia (sub-Tenon's, peribulbar, and retrobulbar). 1 The incidence of TRAO has not been evaluated in prospective longitudinal case finding studies, although it can be considered as a rare event. 1 We present the largest case series reported of TRAO following phacoemulsification under sub-Tenon's anaesthesia.
TRAO is likely to represent a clinical continuum: clinical features such as reduced acuity, visual field loss, and colour deficits may variably be present, 2,3 influenced by the anatomical location, extent and duration of vascular occlusion, or spasm. 4, 5 A duration of anoxia of 44 h exceeds the retina's maximal survival time, 6 although neuronal cell death may occur within 97 min. 7 TRAO of very short duration may not produce visual symptoms, 1 and further investigation will not be sought. An intermediate duration of occlusion will result in symptoms 1, 3, 8 despite arteriolar reperfusion proven on FFA; these patients are labelled as having suffered TRAO. 1 TRAO may be easily overlooked in the post-operative period. Patients who experience mild early symptoms may not consider them significant, or another clinical finding may be offered by the ophthalmologist (refractive error, post-operative inflammation, and so on) to explain them. Patients with persistent symptoms (reduced visual acuity, colour perception, or field loss) may undergo OCT specifically to exclude foveal cystic macular oedema or FFA to exclude arterial occlusion-neither of which will correctly identify TRAO. Visual acuity improving with a pinhole correction may be present in patients with TRAO, perhaps secondary to a diffractive phenomenon consequent to inner retinal oedema. This may erroneously direct diagnostic thinking towards a refractive aetiology of visual loss and delay the diagnosis of TRAO (case 1).
OCT imaging may provide the only objective evidence of TRAO, particularly in patients not presenting in the immediate post-operative period. The acute phase OCT imaging may reveal increased thickness and hyperreflectivity of the inner retina secondary to oedema from the ischaemic event. [9] [10] [11] This may persist for up to 1 month and previously demonstrated maximal on day 3. 12 The inner plexiform layer demonstrates the greatest net change in thickness. 10 OCT evidence of inner retinal atrophy occurs 60-90 days after retinal artery occlusion. [9] [10] [11] [12] OCT examination after several weeks may not reveal retinal thickening owing to the resolution of oedema, before the onset of retinal atrophy (case 1).
OCT findings are subtle and meticulous crosscomparison must be undertaken to diagnose TRAO; there are no easily identifiable cystic changes. 'Branchpattern' TRAO may reveal asymmetry of inner retinal appearance between the superior and inferior macula (case 2). 'Central-pattern' TRAO may reveal inner retinal asymmetry between right and left eyes (cases 1 and 3). Segmentation volumetric analysis of OCT images may add objective measures of inner retinal thickness to document acute-phase oedema and late-phase atrophy, supporting a diagnosis of TRAO. 10 Identification of TRAO is difficult: case 1 was diagnosed retrospectively on re-examination of OCT images following our experience with cases 2 and 3.
The mechanism of TRAO following phacoemulsification cataract surgery in this series remains unclear. The small volumes of sub-Tenon's lignocaine without adrenaline used suggest that raised orbital and intraocular pressure exceeding mean arterial pressure, or pharmacological vasoconstriction unlikely. No other systemic or ocular parameter was identified as contributory, although a prospective case-finding study is required to identify risk factors. We therefore suggest that TRAO may be an idiosyncratic occurrence. Sub-Tenon's anaesthesia is considered safe, but it is possible that even small volumes may contribute to the risk of TRAO; use of topical and intracameral anaesthetic may conceivably reduce the risk of TRAO. Augmentation with subconjunctival lignocaine adjacent to corneal wounds may reduce perception of surgical stimuli for less co-operative patients.
Post-operative TRAO is a difficult diagnosis. Ophthalmologists must be aware of TRAO as a cause of 'pad off' visual loss following phacoemulsification surgery and meticulously cross-compare inner retinal appearance on OCT imaging between healthy and affected eyes. 
